"This is a historic moment for 4DMT as we become a Phase 3 company following our initiation of the 4FRONT-1 clinical trial,” said David Kirn, M.D., Co-founder and Chief Executive Officer of 4DMT.
D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted ...
US: MSI Raider 18 HX | From $3,899.99 at Newegg You can pre-order the RTX 5090 MSI Raider at Newegg for as little as $3,899.99. That gets you an RTX 5080 GPU with a Ryzen 9 processor.
Q4 2024 Earnings Call Transcript March 7, 2025 Operator: Good morning, and welcome to the Molecular Partners Fourth Quarter ...
As a result, cash runway extended into 2028 and includes full execution and topline 52-week data from 4FRONT-1 and 4FRONT-2 Phase 3 clinical trials in wet AMD, and ongoing Phase 1 & 2 clinical ...
Presented positive interim data through 52 weeks and beyond for 4D-150 in wet AMD from PRISM Phase 1/2 clinical trial highlighting robust and durable clinical activity across diverse patient populatio ...
While AMD’s first Zen 5 CPUs disappointed everyone in gaming, the latest X3D versions have more than made up for that. The ...
The AMD Radeon RX 9070 arrives in a weird time for ... That’s an 11% lead in another game that throws Nvidia’s logo at you as you load into it. Red Dead Redemption 2 gives the RX 9070 another ...
For the last couple of generations, AMD has been desperately trying to compete with Nvidia at the high end. However, now, with the AMD Radeon RX 9070 XT, Team Red has ceded the ultra-high-end to ...
The RX 9070 XT GPU, if it’s real, was likely given out to AMD’s brand partners prior to the launch of the RX 9070 XT/non-XT. Whoever got their hands on this card ended up keeping it and selling it, ...
Shares in Advanced Micro Devices (AMD) climbed today despite China throwing down another technological gauntlet to the U.S. with a new $11 ...
What just happened? The rumor that AMD is developing a 32GB version of the RX 9070 XT was always a little shaky, given its source. Now, the claims have been debunked by the company itself.